Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.60
Bid: 7.50
Ask: 7.70
Change: -0.26 (-3.31%)
Spread: 0.20 (2.667%)
Open: 7.75
High: 7.60
Low: 7.60
Prev. Close: 7.86
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Apr 2013 12:34

RNS Number : 3621C
Port Erin Biopharma Investments Ltd
15 April 2013
 



Port Erin Biopharma Investments Limited

("Port Erin" or "the Company")

Changes to the Group's Board

The Board of Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, announces that Nicholas Woolard has informed the Board of his decision to stand down as a Non-Executive Director of the Company with immediate effect in order to allow him to focus on other business interests. Nicholas joined the Board in May 2011 prior to the Company's listing in September 2011, and has served on its Audit and Remuneration committees since that date.

The Board further announces the appointment of Alexander Anderson Stuart Whamond as a Non-Executive Director of the Company with immediate effect. Anderson, aged 52, has over 25 years' experience in the banking and financial sector. He began his career in 1983 at White Weld Securities (part of the CSFB group) before joining Salomon Brothers International in London in 1986 and then Morgan Stanley International in 1989 where he was a principal in charge of convertible bond trading. He joined Peregrine Securities International (UK) Limited in 1993, relocating to Hong Kong in 1996 to run the equity trading businesses of Peregrine Investment Holdings Limited and becoming a director of the executive committee of the Peregrine group in 1997. In 1998, Anderson joined the Regent Pacific Group, a Hong Kong listed international emerging markets investments group, as head of corporate investments and relocated to the Isle of Man. He joined the Charlemagne Group in 2002 and was a director of AIM quoted Charlemagne Capital Limited until March 2009. He remains a non-executive director of Charlemagne Capital (IOM) Limited and is also a director of a number of listed and non-listed investment companies.

Anderson Whamond will chair both the Audit and Remuneration committees.

Jim Mellon, Chairman, commented: "Nick has made a very significant contribution to Port Erin. I would like to thank Nick on behalf of the Board for his advice and support and to wish him well for the future. I also have great pleasure in welcoming Anderson to the board, bringing as he does a wealth of experience in the investment arena."

Anderson Whamond's Directorships:-

Current Directorships

 

Atherton Electrontics Group Limited

Charlemagne Bric Plus Real Estate Company Ltd

Charlemagne Bric Property Plus Company Plc

Charlemagne Capital (IOM) Limited

Charlemagne Capital (Services) Limited

Charlemagne New Frontiers Fund

Cherrywood Consulting Limited

European Convergence Development Company Ltd

European Convergence Property Company plc

Holmeglen Limited

Interman Limited

Magna Umbrella Fund Plc

MHA Lighting Limited

OCCO Eastern European Fund

Rothesay Limited

 

Previous Directorships

 

Appleyard Investments Limited

Asian Debt Fund

Asian Fortune Enterprises Limited

Asian Opportunities Fund 1998 - I

Bald Eagle Asian Equities (non US Feeder) Fund

Bald Eagle Asian Equities Fund

Balkan Holdings (Cyprus) Limited

Burnbrae Limited

Charlemagne Capital (Barbados) Limited

Charlemagne Capital (Advisory) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital (Caymen) Limited

Charlemagne Capital (Property) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital Russia Fund

Charlemagne Capital Limited

Charlemagne CIS Fund Limited

Charlemagne CIS Fund (Labuan) Limited

Charlemagne Finance (Cyprus) Limited

Charlemagne Emerging Markets Fund Plc

Daeyu Regent Securities Limited

Clefex.com (IOM) Limited

EEPF (Cyprus) Limited

Diamond River International Limited

Gold Victory Holdings Limited

EIH Plc

Homeport (Cayman) Limited

Hermes Softlab d.d.

Interman Services Limited

Interman Europe plc

International Fund Arbitrage

Interman UK Limited

Ironwood Enterprises LLC

Ireton Enterprises Limited

JEM Limited

Ironwood Partnership Limited

Navrona Investments Limited

Lattice Limited

Naya Bharat Property Company Plc

Naya Bharat Property Company (Mauritius) Ltd

Novy Neft Limited

Novy Neft II Limited

Oasis Group Limited

Nowe Finanse Limited

OCCO Global Emerging Markets Fund

OCCO Asia Fund

OCCO Latin America Fund Plc

OCCO Latin America Fund

Peregrine Securities (UK) Limited

Peregrine Brokerage Limited

Port Antonio Limited

Port Antonio Developments (St. Lucia) Limited

Quayle Munro Infrastructure Company Plc

Portland Investment Company Limited

Regent European Securities (Cayman) Limited

Regent Fund Management Limited

Regent Pacific Corporate Advisory Limited

Regent Magna Europa (Cyprus) Limited

Regent Pacific Fund

Regent Pacific Energy Limited

Regent Pacific Private Equity Limited

Regent Pacific Group Limited

RPG(L) Limited

Regent Russian Bond Fund

Sleepwell Hotels (UK) Limited

Sidebottom Holdings Limited

South Asia Fund

Sleepwell Hotels Limited

Spanish Off-Plan Properties Plc

Southwise Trading Limited

SWB Investments Limited

SWA Holdings Limited

TBF(Cyprus) Limited

SWR Investments Limited

Turtle Crawl Hill Limited

Techpacific.com Limited

Ukraine Investment Fund

UAR Investments Limited

Undervalued Assets Fund - Series V Plc

Undervalued Assets Fund - Series One

Undervalued Assets Thailand Fund

Undervalued Assets Property Fund - Series Two

Undervalued Opportunities Company Limited

Undervalued Opportunities (Master) Company Ltd

WTIC Limited

Walker Telecommunications Limited

 

Ends

For further information:

For further information, please contact:

Port Erin Biopharma Investments Ltd

Libertas Capital Corporate Finance Limited

Peterhouse Capital Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

+44 162 463 9396

Sandy Jamieson

+44 207 569 9650

Jon Levinson

+44 207 562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDMKFGFZM
Date   Source Headline
2nd Aug 20237:00 amRNSNet Asset Value calculation at 30 June 2023
18th Jul 20239:14 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSPortfolio Company Update: Galy Co. Update
11th Jul 202311:33 amRNSExercise of Warrants and TVR
22nd Jun 20231:06 pmRNSCultivated Meat Approved for Sale in the US
22nd Jun 202312:42 pmRNSPortfolio Company CellX Raises US$ 6.5 million
22nd Jun 202310:00 amRNSGood Dog Food raises investment from Pets at Home
16th Jun 20237:00 amRNSUSDA Gives First Label Approval to Lab Grown Meat
15th Jun 20237:00 amRNSAUD 2.5 million investment in HydGene Renewables
14th Jun 20237:00 amRNSAgronomics Appoints Comms Consultancy
1st Jun 20237:00 amRNSReplacement Warrant Final Exercise Dates Extension
31st May 20237:00 amRNSExtension of Warrant Final Exercise Dates
9th May 20232:08 pmRNSDirectors' Dealings
4th May 20237:00 amRNSInvestee Company Update: Good Dog Food
2nd May 202311:38 amRNSNet Asset Value calculation as at 31 March 2023
14th Apr 202310:19 amRNSExercise of Warrants and TVR
12th Apr 202312:00 pmRNSInvestee Company Update: Liberation Labs
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 202311:50 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSFood Fermentation Europe launches
15th Mar 20237:00 amRNSDirectors’ interests in shares
10th Mar 20237:15 amRNSEdison issues update on Agronomics (ANIC)
2nd Mar 20235:50 pmRNSHolding(s) in Company
23rd Feb 20238:00 amRNSANIC invests in Wild Microbes US$3.3m Financing
23rd Feb 20237:00 amRNSAgronomics Welcomes Marisa Drew as a Director
20th Feb 20237:00 amRNSPrecision Fermentation Alliance Formed
9th Feb 20239:00 amRNSAgronomics February 2023 Newsletter
8th Feb 20237:00 amRNSUnaudited Interim Results
7th Feb 20234:49 pmRNSInvestee Company Update: CellX
2nd Feb 202311:04 amRNSResult of AGM
25th Jan 20237:00 amRNSNet Asset Value calculation at 31 December 2022
25th Jan 20237:00 amRNSInvestee company Update: Liberation Labs
4th Jan 20237:00 amRNSPerformance Shares issued to Shellbay Investments
30th Dec 202212:00 pmRNSPortfolio Company Update: Liberation Labs
23rd Dec 20227:00 amRNSSolar Foods receives Euro34 million in grant
20th Dec 20229:00 amRNSFinal Results
5th Dec 20229:18 amRNSInvestee Company Update: Clean Food Group
5th Dec 20227:00 amRNSFurther Investment in Liberation Labs Seed Round
28th Nov 20227:00 amRNSHolding(s) in Company
23rd Nov 20225:59 pmRNSHolding(s) in Company
17th Nov 20227:30 amRNSFirst Cultivated Meat Company gets FDA approval
3rd Nov 20227:00 amRNSAgronomics Capital Markets Day 3rd November
27th Oct 202212:02 pmRNSDirector Dealings
26th Oct 20229:30 amRNSPortfolio Company Solar Foods Update
20th Oct 20227:00 amRNSInvestment in Liberation Labs US$ 20m fundraise
19th Oct 20229:00 amRNSAgronomics October 2022 Newsletter
19th Oct 20227:00 amRNSNet Asset Value calculation to 30 September 2022
12th Oct 20228:53 amRNSHolding(s) in Company
11th Oct 20227:00 amRNSExercise of Warrants & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.